FSR-16m

N/A

Report date: 2025/01/26 17:16:30

Base Information

Drug NameFSR-16m
Drug Alias NameHomo-trimeric DARPin (Texas A&M University)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTexas A&M University System
China Registration ClassN/A

Develop Information

Active CompaniesTexas A&M University System
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A